Ledger.Open graph →
SEC Form D · filed June 13, 2025

Maxona Pharmaceuticals, Inc

Offering
$5.0M
Sold
$900K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Malvern, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

David Nakamura · King of Prussia, PADirectorShahin Fatholahi · King of Prussia, PAExec · DirectorRichard Brand · New York, NYExecBehshad Sheldon · Baltimore, MDDirectorDavid Nakamura · King of Prussia, PADirectorShahin Fatholahi · King of Prussia, PAExec · DirectorRichard Brand · New York, NYExecBehshad Sheldon · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗